Q4 Highlights New advanced X-ray product Altumira™ Plus with scatter correction released Participation in world’s largest medical imaging conference, Radiological Society of North America (RSNA) Increasing interest from customers and OEMs in our products Strategic investments in Point of Care Ultrasound (POCUS), R&D and Quality Management Q4 Financial Data Record Q4 Net Sales of 33.2 […]
With a record revenue and a solid EBITDA margin of 44% in Q3 as well as the first nine months, the company reaffirms its foundation for growth. The strong performance is driven by a healthy core business supported by investments in growth initiatives such as the AI-based X-ray solution, Altumira. STOCKHOLM – October 26, 2023. […]
ContextVision is pleased to announce the appointment of Richard Hallström as a Chief Financial Officer (CFO), effective today 28th of August. He succeeds Markus Hökerberg, who has acted as an Interim CFO.
“Our impressive performance was fuelled by the excellent licensing sales in our core business and boosted by favourable foreign exchange rates. We anticipate our margins to remain stable, consistently reaching a high level of 40 in the foreseeable future”, says Gerald Pötzsch, CEO of ContextVision.
On May 3rd 2023, ContextVision held its ordinary Shareholders’ Annual General Meeting in Stockholm. The company’s robust growth in 2022 and the successful spin off of Inify Laboratories AB has resulted in a strong balance sheet. In the light of this background and in line with the board’s recommendation, the Meeting resolved on a dividend […]
STOCKHOLM – March 30, 2023 – ContextVision hereby invites shareholders to the Annual General Meeting on May 3, 2023. Please find attached the invitation including agenda and details on how to register and vote. Please contact: for any questions regarding the AGM. For inquiries, please contact CFO Markus Hökerberg E-mail: